Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 5G3 TalkMed > Key Indicators
5G3 TalkMed
0.400
+0.020+5.26%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(FY)2021/12/31(Q4)2021/12/31(Q2)2021/06/30
Financial Ratios
Efficiency Ratios
Receivable Turnover (T)
-- -- 14.08% 6.7193 -- -- -- --
Fixed Assets Turnover (T)
-- -- -0.74% 8.2726 -- -- -- --
Total Asset Rate (T)
-- -- -3.48% 0.5693 -- -- -- --
ROE
-- -- 5.81% 28.932% -- -- -- --
ROA
-- -- 8.90% 23.537% -- -- -- --
ROIC
-- -- 7.25% 26.106% -- -- -- --
FCF to Salese
-- -- -21.89% 36.855% -- -- -- --
FCF to Net Income
-- -- -30.77% 89.142% -- -- -- --
Profitability Ratios
EBIT Margin
-- -- 11.77% 45.562% -- -- -- --
Net Margin
-- -- 12.83% 41.344% -- -- -- --
EBITDA Margin
-- -- 6.98% 49.658% -- -- -- --
Tax Rate
-- -- -15.33% 21.469% -- -- -- --
Interest Coverage (T)
-- -- 46.15% 70.7852 -- -- -- --
R & D Expense Ratio
-- -- -- 0.000% -- -- -- --
Sales Expense Ratio
-- -- -- 0.000% -- -- -- --
Administration Expense Rate
-- -- -- 0.000% -- -- -- --
Financial Health Ratios
Long-Term Debt to Equity Ratio
21.35% 6.765% -21.97% 7.807% -21.97% 7.807% -38.95% 5.575%
Total Assets to Common Equity Ratio
-0.72% 119.230% -3.80% 120.634% -3.80% 120.634% -8.06% 120.100%
Interest-Bearing Liabilities To Asset Ratio
30.17% 7.526% -14.44% 8.287% -14.44% 8.287% -34.84% 5.782%
Current Ratio
-6.63% 6.4222 23.71% 6.4882 23.71% 6.4882 46.68% 6.8779
Quick Ratio
-6.43% 6.3276 24.16% 6.3709 24.16% 6.3709 47.15% 6.7621
Growth Ratios
Growth Ratios
Revenue CAGR (3Y)
-- -- -169.23% -0.290% -- -- -- --
Revenue CAGR (5Y)
-- -- -123.62% -2.491% -- -- -- --
Net Income CAGR (3Y)
-- -- 57.43% -4.580% -- -- -- --
Net Income CAGR (5Y)
-- -- 18.75% -7.651% -- -- -- --
Dividend CAGR (3Y)
-- -- -27,399.54% -12.045% -- -- -- --
Dividend  CAGR (5Y)
-- -- -284.13% -15.831% -- -- -- --
FCF  CAGR (3Y)
-- -- -299.34% -5.046% -- -- -- --
FCF  CAGR (5Y)
-- -- -116.73% -12.862% -- -- -- --
FCF CAGR (1Y)
-- -- -79.88% -23.640% -- -- -- --
Currency Unit
SGDSGDSGDSGD

Q6, Q9, and FY are cumulative quarterly reports: Q6 is the interim report; Q9 is third quarter report; FY is the annual report.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
TalkMed Group Ltd operates as an investment holding company. The principal activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.
CEO: --
Market: --
Watchlist